Johnson & Johnson recalls baby powder as asbestos trace is discovered in one bottle

Johnson & Johnson recalls baby powder as asbestos trace is discovered in one bottle

World’s largest healthcare company, Johnson & Johnson on Friday, (October 18) recalled a single batch of its baby powder as a precaution after government testing found trace amounts of asbestos in one bottle bought online.

The recalled lot consists of 33,000 bottles which were distributed last year.

J&J said the U.S. Food and Drug Administration found minuscule amounts of asbestos in one bottle during routine testing and notified the company on Thursday. J&J said it immediately began  investigating with the FDA.

“The FDA’s testing on prior occasions, and as recently as last month, found no asbestos,” said spokesman Ernie Knewitz.

J&J said it was checking where the bottles were shipped, if the tested bottle is counterfeit or authentic and whether the sample might have been contaminated during testing.

The recall comes as J&J fights thousands of lawsuits in which plaintiffs claim its iconic baby talcum powder was contaminated with asbestos and that it caused ovarian cancer or mesothelioma, a rare cancer linked to inhaling asbestos fibers.

At multiple trials, J&J’s expert witnesses have testified asbestos hasn’t been detected in the talc in its baby powder in thousands of tests over the last 40 years. Several juries have reached multimillion-dollar verdicts against the company, nearly all of which are being appealed or have been overturned on appeal.

Talc, the softest of minerals, is mined from deposits around the world, which can be contaminated with asbestos. J&J says the company and its talc suppliers routinely test their talc to ensure there’s no asbestos. The talc is then crushed into a white powder and purified for use in personal care products to absorb moisture.

The recalled lot of 22-ounce bottles is #22318RB. Consumers who have a bottle from that lot should stop using it; refunds are available through the company’s website.

The company’s shares dropped 5% to $129.33 at midday Friday, following the recall news and, just a day earlier, the announcement of a $117 million settlement with 41 states over allegations the company deceptively marketed its pelvic mesh products by concealing risks.

– Courtesy: Time Magazine

About author

You might also like

Lagos shuts 20 health facilitate for non-compliance  with regulatory standards

assures  public of efficient service delivery via E-HEFAMAA No fewer than 20 health facilities were shut down by the Lagos State Government through the Health Facility Monitoring and Accreditation Agency

World Antibiotic Awareness Week: St Racheal’s Pharma to conduct Resistance Surveillance

  As Nigeria joined the rest of the world to mark the 2018 World Antibiotic Awareness Week  (WAAW), one of Nigeria’s leading antibiotic manufacturers and marketers, St Racheal’s  Pharma has

Ipas collaborates with Australian govt on sign language interpreters in Abuja govt hospitals

  By Adeola Tukuru, Abuja  Ipas Nigeria, a non- governmental organization in collaboration with the Australian Government in Nigeria to established sign-language interpreters in selected government hospitals in FCT where

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply